TGM2 and ovarian carcinoma: Moreover, TG2 has been associated with the accumulation of β-catenin, normally stimulated by activation of the Wnt pathway, which translocates to the nucleus and stimulates expression of CyclinD-1 and c-Myc, maintaining proliferation of ovarian cancer cells [23].